Skip to main content
. 2018 Apr 3;9(25):17554–17563. doi: 10.18632/oncotarget.24785

Figure 3.

Figure 3

Kaplan-Meier analysis of time to progression (TTP) (A) and overall survival (OS) (B) in NSCLC patients according to the baseline cPD-L1 status.